A Long-Term Safety and Tolerability Study of ALKS 3831 in Adults With Schizophrenia

Status:
Completed

Trial end date:
2018-06-29

Target enrollment:

Participant gender:

The primary objective of this study is to evaluate the long term safety and tolerability of ALKS 3831 in subjects with schizophrenia.

Phase 3

Alkermes, Inc.